Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.contraception.2005.09.005
DC FieldValue
dc.titleActinomyces in cervical smears of women using the intrauterine device in Singapore
dc.contributor.authorKalaichelvan, V.
dc.contributor.authorMaw, A.A.
dc.contributor.authorSingh, K.
dc.date.accessioned2011-09-15T08:21:59Z
dc.date.available2011-09-15T08:21:59Z
dc.date.issued2006
dc.identifier.citationKalaichelvan, V., Maw, A.A., Singh, K. (2006). Actinomyces in cervical smears of women using the intrauterine device in Singapore. Contraception 73 (4) : 352-355. ScholarBank@NUS Repository. https://doi.org/10.1016/j.contraception.2005.09.005
dc.identifier.issn00107824
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/26008
dc.description.abstractObjectives: Reproductive tract actinomyces have been associated with the use of intrauterine contraceptive device (IUCD). Thus, there is a need to evaluate the prevalence of colonization with Actinomyces israelii in a cohort of Singaporean women using an IUCD. Second, the occurrence of actinomycosis in colonized women and the clinical need to remove the IUCD and/or possibly the need to treat asymptomatic carriers with antibiotics were evaluated. Methods: The study population consisted of 1108 IUCD users attending the Fertility Control Clinic, National University Hospital, Singapore. Results: In our study, the prevalence of actinomyces-positive cervical smears among IUCD users was 13.7%; the incidence of actinomyces-positive smears was similar with Copper T (34.2%), Multiload (32.9%) and Nova T (32.9%) IUCDs. We found no association with the duration of use of IUCD and actinomyces infection. In our study, 150 out of 152 (98.7%) IUCD users with actinomyces-positive smears were asymptomatic, and only 2 out of 152 (1.3%) who had actinomyces-positive cervical smears developed pelvic inflammatory disease at 6 months. Conclusions: Our study suggests that removal of the IUCD in asymptomatic women with actinomyces-positive cervical smear is not necessary. Moreover, we suggest that asymptomatic carriers of actinomyces do not require preemptive antibiotic treatment. © 2006 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.contraception.2005.09.005
dc.sourceScopus
dc.subjectActinomyces
dc.subjectCervical smears
dc.subjectIntrauterine device use
dc.typeArticle
dc.contributor.departmentOBSTETRICS & GYNAECOLOGY
dc.description.doi10.1016/j.contraception.2005.09.005
dc.description.sourcetitleContraception
dc.description.volume73
dc.description.issue4
dc.description.page352-355
dc.identifier.isiut000236377500007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.